Louhelainen J, Wijkström H, Hemminki K
ICRF Cancer Medicine Research Unit, Cancer Research Building, St James's University Hospital, Leeds LS9 7TF, UK.
Int J Oncol. 2001 Jan;18(1):203-10. doi: 10.3892/ijo.18.1.203.
We have examined six patients with multiple low grade, low stage superficial multifocal bladder tumors with surrounding tissues for loss of heterozygosity (LOH) and microsatellite instability at chromosome 3, totaling 76 samples. The majority (4/5) of the patients had LOH at or close to the fragile histidine triad (FHIT) gene (3p14.2; D3S1300), which is a candidate tumor suppressor gene for many cancer types. One patient showed a consistent LOH with four adjacent markers around FHIT region in all the tumors whereas in the corresponding surrounding tissues the heterozygosity was retained. In addition to the region near FHIT, two other regions had frequent allelic losses - one near the p telomere (3p25-26; D3S3050) and another near the q telomere (3q27; D3S2418). The largest numbers of LOH in the surrounding tissues were found at these regions (3/5 at D3S3050 and 2/5 at D3S2418). The D3S3050 marker is located at 3p26-3p25, near the Von Hippel-Lindau (VHL) tumor suppressor gene locus. LOH that were more random were found at 3q21.3-25.2 (D3S1744) and at 3p12-3p11 (D3S2465). Taken together, at least three regions at chromosome 3p25-26, 3p14.2 and 3q27 seem to have frequent loss of heterozygosity in multifocal superficial bladder tumors. We also performed a phylogenetic-type analysis to find out common changes and the degree of heterogeneity. The overall heterogeneity was low within a given patient: in all cases the majority of the tumor samples arranged in a single branch with a common origin. This point of origin varied from patient to patient, which is compatible with the earlier studies demonstrating the heterogeneity of the single primary bladder tumors. However, the phylogenetic-type analysis suggests that the FHIT region contains often the very first alterations at chromosome 3.
我们检查了6例患有多个低级别、低分期浅表多灶性膀胱肿瘤的患者及其周围组织,以检测3号染色体上的杂合性缺失(LOH)和微卫星不稳定性,共76个样本。大多数(4/5)患者在脆性组氨酸三联体(FHIT)基因(3p14.2;D3S1300)处或其附近存在杂合性缺失,该基因是多种癌症类型的候选肿瘤抑制基因。1例患者在所有肿瘤中均显示FHIT区域周围有4个相邻标记物的一致杂合性缺失,而在相应的周围组织中杂合性得以保留。除了FHIT附近区域外,另外两个区域也频繁出现等位基因缺失——一个在p端粒附近(3p25 - 26;D3S3050),另一个在q端粒附近(3q27;D3S2418)。在这些区域发现周围组织中杂合性缺失的数量最多(D3S3050处为3/5,D3S2418处为2/5)。D3S3050标记位于3p26 - 3p25,靠近冯·希佩尔 - 林道(VHL)肿瘤抑制基因位点。在3q21.3 - 25.2(D3S1744)和3p12 - 3p11(D3S2465)发现的杂合性缺失更为随机。综上所述,在3号染色体的3p25 - 26、3p14.2和3q27至少有三个区域在多灶性浅表膀胱肿瘤中似乎频繁出现杂合性缺失。我们还进行了系统发育类型分析以找出共同变化和异质性程度。在给定患者中总体异质性较低:在所有病例中,大多数肿瘤样本排列在一个具有共同起源的单一分支中。这个起源点因患者而异,这与早期研究证明单一原发性膀胱肿瘤的异质性是相符的。然而,系统发育类型分析表明,FHIT区域通常包含3号染色体上最早的改变。